Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001475559 | SCV001679753 | likely benign | Fanconi anemia | 2024-09-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000931430 | SCV002002592 | uncertain significance | not provided | 2022-10-20 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000931430 | SCV004218779 | likely benign | not provided | 2022-12-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004973182 | SCV005580737 | likely benign | Inborn genetic diseases | 2024-10-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004738088 | SCV005351094 | likely benign | FANCM-related disorder | 2024-04-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |